Short- and long-course levofloxacin plus rifampicin for prosthetic joint infection
Short- and long-course levofloxacin plus rifampicin for prosthetic joint infection
Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial
Int J Antimicrob Agents. 2016 Sep;48(3):310-6Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
63 patients with a hip or knee prosthetic joint infection by either Staphylococcus aureus or coagulase-negative staphylococci were randomized to either 8 weeks of levofloxacin and rifampicin following debridement, or 3- and 6-months levofloxacin and rifampicin following debridement (3 months for hip infection and 6 months for knee infection). The purpose of this study was to compare infection cure...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.